120 related articles for article (PubMed ID: 2104648)
1. Systemic administration of radionuclides in neuroblastoma as planned radiotherapeutic intervention.
Lashford LS; Clarke J; Kemshead JT
Med Pediatr Oncol; 1990; 18(1):30-6. PubMed ID: 2104648
[No Abstract] [Full Text] [Related]
2. Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma.
Mairs RJ; Angerson WJ; Babich JW; Murray T
Prog Clin Biol Res; 1991; 366():495-501. PubMed ID: 2068165
[TBL] [Abstract][Full Text] [Related]
3. The distribution of alternative agents for targeted radiotherapy within human neuroblastoma spheroids.
Mairs RJ; Angerson W; Gaze MN; Murray T; Babich JW; Reid R; McSharry C
Br J Cancer; 1991 Mar; 63(3):404-9. PubMed ID: 2003981
[TBL] [Abstract][Full Text] [Related]
4. The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma.
Lashford LS; Moyes J; Ott R; Fielding S; Babich J; Mellors S; Gordon I; Evans K; Kemshead JT
Eur J Nucl Med; 1988; 13(11):574-7. PubMed ID: 3350034
[TBL] [Abstract][Full Text] [Related]
5. The use of an investigational radiopharmaceutical in neuroblastoma: a nursing perspective.
Kelly JU
J Pediatr Oncol Nurs; 1989 Oct; 6(4):133-8. PubMed ID: 2604936
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic use of I-131-MIBG in nude mice hosting human neuroblastoma xenografts.
Senekowitsch R; Laubenbacher C; Möllenstädt S; Kriegel H; Pabst HW
Strahlenther Onkol; 1989 Jul; 165(7):566-8. PubMed ID: 2749502
[No Abstract] [Full Text] [Related]
7. [Clinical applications of radio-labelled mIBG].
Lumbroso J; Schlumberger M
Rev Prat; 1990 Jan; 40(2):140-2. PubMed ID: 2300771
[No Abstract] [Full Text] [Related]
8. Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children.
Bolster AA; Hilditch TE
Br J Radiol; 1995 Nov; 68(815):1263. PubMed ID: 8542240
[No Abstract] [Full Text] [Related]
9. Radiolabelled mIBG in the treatment of neuroblastoma.
Gaze MN; Wheldon TE
Eur J Cancer; 1996 Jan; 32A(1):93-6. PubMed ID: 8695251
[No Abstract] [Full Text] [Related]
10. Radiation dosimetry for 131I-mIBG therapy of neuroblastoma.
Flower MA; Fielding SL
Phys Med Biol; 1996 Oct; 41(10):1933-40. PubMed ID: 8912372
[TBL] [Abstract][Full Text] [Related]
11. 131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.
Hutchinson RJ; Sisson JC; Shapiro B; Miser JS; Normole D; Shulkin BL; Francis IR; Zasadny K; Carey JE; Johnson JW
Am J Clin Oncol; 1992 Jun; 15(3):226-32. PubMed ID: 1590275
[TBL] [Abstract][Full Text] [Related]
12. Can preirradiation enhance tumor uptake of radiolabeled pharmaceuticals? Experimental data in a mouse neuroblastoma xenograft system.
Sautter-Bihl ML; Bihl H
Recent Results Cancer Res; 1996; 141():123-35. PubMed ID: 8722423
[No Abstract] [Full Text] [Related]
13. Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
Prog Clin Biol Res; 1991; 366():455-61. PubMed ID: 2068160
[No Abstract] [Full Text] [Related]
14. A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.
Rutgers M; Gubbels AA; Hoefnagel CA; Voûte PA; Smets LA
Prog Clin Biol Res; 1991; 366():471-8. PubMed ID: 2068162
[No Abstract] [Full Text] [Related]
15. The treatment of neuroblastoma with 131I-MIBG.
Mastrangelo R
Med Pediatr Oncol; 1987; 15(4):157-8. PubMed ID: 3657703
[No Abstract] [Full Text] [Related]
16. Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study.
Fielding SL; Flower MA; Ackery D; Kemshead JT; Lashford LS; Lewis I
Eur J Nucl Med; 1991; 18(5):308-16. PubMed ID: 1936038
[TBL] [Abstract][Full Text] [Related]
17. Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
Klingebiel T; Bruchelt G; Kaleva N; Wollmann H; Handgretinger R; Treuner J; Gupta D; Niethammer D
Prog Clin Biol Res; 1991; 366():509-12. PubMed ID: 2068167
[No Abstract] [Full Text] [Related]
18. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
[No Abstract] [Full Text] [Related]
19. Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG).
Brendel AJ; Jeandot R; Guyot M; Lambert B; Drouillard J
Clin Nucl Med; 1989 Jan; 14(1):19-21. PubMed ID: 2714036
[No Abstract] [Full Text] [Related]
20. New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.
Mairs RJ; Zalutsky MR
Br J Cancer; 1995 Jul; 72(1):250. PubMed ID: 7599061
[No Abstract] [Full Text] [Related]
[Next] [New Search]
